Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Nutrient Synergy, Inc
WARNING LETTER
•Nutrient Synergy, Inc•June 30, 2013

Nutrient Synergy, Inc – FDA Warning Letter, Jun 30, 2013

Record Details

The FDA issued a Warning Letter to Nutrient Synergy, Inc. after reviewing their website (www.nutrientsynergy.com) in June 2013, determining that their product, Nepretin, is promoted for conditions that classify it as a drug under the Federal Food, Drug, and Cosmetic Act. The website and product label contain therapeutic claims, including "revolutionary treatment for diabetic retinopathy and nephropathy," and "designed to control complications of diabetes," indicating intent for use in disease cure, mitigation, treatment, or prevention.

Examples of claims cited include Nepretin slowing, stopping, or reversing diabetic retinopathy symptoms, improving eye grade, glycohemoglobin rates, albumin excretion rates, blood pressure, and reducing insulin needs. Testimonials also describe Nepretin's use for treating advanced diabetes, improving eyesight, and stopping eye bleeding. Metatags like "diabetes nephropathy treatment" further support the drug claims.

Nepretin is deemed a "new drug" because it is not generally recognized as safe and effective for these uses and lacks FDA approval, violating sections 201(p) and 505(a) of the Act. Furthermore, it is misbranded under section 502(f)(1) because adequate directions for use cannot be provided for self-diagnosis and treatment by laypersons.

The FDA previously informed Nutrient Synergy of these violations during a June 6, 2013, conference call, where the

Company
Nutrient Synergy, Inc
Inspection date
June 30, 2013
Product type
Drugs
Office
Denver District Office
Person
  • Latonya Mitchell (District Director)
View Company Profile

ID · 3ea74421-b357-493b-8559-5df91e45192b

Violation Codes6
21 U.S.C. 331(a)21 U.S.C. 321(b)(1)(B)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 352(f)(1)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nutrient Synergy, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.